Erik Ekman
Direktor/Vorstandsmitglied bei ICONOVO AB
Profil
Erik Ekman is currently the Chief Executive Officer at Bluefish Pharmaceuticals AB since 2017 and the Director at Iconovo AB since 2024.
He graduated from the University of Linköping.
Aktive Positionen von Erik Ekman
| Unternehmen | Position | Beginn |
|---|---|---|
| ICONOVO AB | Direktor/Vorstandsmitglied | 01.01.2024 |
Bluefish Pharmaceuticals AB
 Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Bluefish Pharmaceuticals AB manufactures generic pharmaceutical products. Its therapeutic areas include analgesic, antibiotics, antifungal, antiviral, cardiovascular, endocrinology, diabetes, gastrointestinal, genito-urinary, inflammatory, oncology, and respiratory. The company was founded by Karl Alexius Tiger Karlsson in 2005 and is headquartered in Stockholm, Sweden. | Vorstandsvorsitzender | 01.11.2017 |
Ausbildung von Erik Ekman
| University of Linköping | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ICONOVO AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Bluefish Pharmaceuticals AB manufactures generic pharmaceutical products. Its therapeutic areas include analgesic, antibiotics, antifungal, antiviral, cardiovascular, endocrinology, diabetes, gastrointestinal, genito-urinary, inflammatory, oncology, and respiratory. The company was founded by Karl Alexius Tiger Karlsson in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |